Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca to take Alzheimer’s drug into phase II

January 5, 2012
Research and Development Alzheimer's, AstraZeneca, Targacept

AstraZeneca is to continue the development of Targacept’s AZD1446 as a treatment for Alzheimer’s disease.AZD1446 is a selective modulator of …

News

UK to expand telehealth to three million people

January 4, 2012
Medical Communications, Sales and Marketing NHS, long term conditions, telecare, telehealth

The NHS is to expand the use of telehealth, allowing doctors to remotely monitor patients with long-term conditions.The government’s Care …

News

Orphan status for haemophilia gene therapy

January 4, 2012
Research and Development AMT, gene therapy, haemophilia

Amsterdam Molecular Therapeutics has been granted an orphan drug designation for its gene therapy for haemophilia B.The FDA’s orphan designation …

News

Missing trial data ‘threatens integrity of medicine’

January 4, 2012
Research and Development, Sales and Marketing BMJ, clincial trial data, disclosure

Missing clinical trial data can harm patients and lead to needless costs for health systems, according to new research. A …

News

Yanai steps down as Teva’s chief executive after four years at the helm

January 3, 2012
Medical Communications Teva

Shlomo Yanai is to step down as the chief executive and president of Teva, the world’s biggest generic drug makers. …

Appointment

NHS leaders say hospital use must be scaled back

January 3, 2012
Sales and Marketing

The NHS Confederation says the government must convince people to let go of the ‘outdated hospital-or-bust’ model of care. Mike …

News

GSK’s Andrew Witty knighted

January 3, 2012
Sales and Marketing Andrew Witty, GSK

GlaxoSmithKline chief executive Andrew Witty and former ABPI director general Richard Barker were among the recipients in the 2012 New …

News

Ben Venue extends plant shutdown

January 3, 2012
Manufacturing and Production Ben Venue

Troubled contract manufacturing organisation Ben Venue Laboratories has said it will have to extend its temporary shutdown of a facility …

News

Pharma manufacturing in brief

January 3, 2012
Manufacturing and Production IGI Laboratories, aseptic packaging

Pharma manufacturing news in briefCPL shuts down a facility in New Jersey, US, Tamer plans a new plant in Saudi …

News

AAIPharma expands in North Carolina

January 3, 2012
Manufacturing and Production AAIPharma

AAIPharma Services is planning to expand its contract analytics facility in Wilmington, North Carolina, with a new 40,000 sq. ft. …

News
p0024

Avastin gains EU licence for ovarian cancer

January 3, 2012
Sales and Marketing Roche, avastin, ovarian

Roche’s Avastin has been granted a new European licence to treat ovarian cancer, which could help offset falling sales of …

News

Introducing SHL’s first White Paper: “Auto Injectors: From Planning to Launch”

January 3, 2012
Manufacturing and Production auto injector, autoinjector, autoinjector manufacturing, autoinjector white paper, shl white paper

SHL is officially introducing the company’s first White Paper on the topic of “Auto Injectors; From Planning to Launch” with …

Feature
White paper

Working Life

January 1, 2012
Working Life

People working in pharma talking about what they like and dislike most about their jobs Mike Crooks, UK general manager, Astellas

Feature

Contract research news in brief

December 23, 2011
Manufacturing and Production AMRI, Frontage Labs, Kymos and Crystal3 Labs, Pacific Biomarkers/Cingene

A round up of news in the CRO sector, including cutbacks at AMRI and updates from Pacific Biomarkers/Clingene, Frontage Labs, …

News

NHS on track to make £358 million in drug savings

December 23, 2011
Sales and Marketing DoH, NHS, QIPP

The NHS in England is set to make £358 million in savings from drugs over the financial year, according to …

News
Ranbaxy picture

Ranbaxy sets aside $500m for manufacturing penalties

December 22, 2011
Manufacturing and Production

Indian drugmaker Ranbaxy Laboratories has set aside $500 million to pay financial penalties levied by the US FDA, resulting from …

News

RSA makes three new appointments

December 22, 2011
Business Services, Medical Communications, Sales and Marketing rsa

Life sciences recruitment firm RSA has announced three new appointments to its UK office. Dr David Jay joins RSA UK …

Appointment

FDA accepts Pfizer’s arthritis pill for review

December 22, 2011
Research and Development, Sales and Marketing FDA, Pfizer, tofacitinib

The FDA has accepted Pfizer’s novel arthritis pill tofacitinib for review, and could be on the US market next year. …

News
GSK picture

GSK sells off over-the-counter brands

December 22, 2011
Sales and Marketing GSK, OTC

GlaxoSmithKline has offloaded a number of OTC consumer health brands in North America for £426 million in cash.  Flagged up …

News

Department of Health slims down agency partners

December 21, 2011
Medical Communications DH, Freud Communications, MEC

The Department of Health has stripped back its use of comms agencies in its public health campaigns by switching to …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026